| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |